Michele Mancini

Also affiliated with Eli Lilly (United States)

Economics, Econometrics and FinanceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Trial of Solanezumab in Preclinical Alzheimer’s Disease”.

Trial of Solanezumab in Preclinical Alzheimer’s Disease

New England Journal of Medicine(2023)10.1056/nejmoa2305032

N/A

4.9DataRank · unranked

390 citations

Michael Donohue, Rema Raman, Michael S. Rafii, Keith Johnson, Colin L. Masters +10 more

Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease

Annals of Neurology(2022)10.1002/ana.26511

N/A

1.8DataRank · unranked

44 citations

Jorge J. Llibre‐Guerra, Yan Li, Austin McCullough, Carsten Hofmann, Jakub Wojtowicz +49 more

Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease

JAMA Neurology(2024)10.1001/jamaneurol.2024.0991

N/A

1.0DataRank · unranked

29 citations

Haiyan Liu, Guoqiao Wang, Xinyu Shi, Tobias Bittner, Marzia A. Scelsi +94 more

Safety Profile of a Cognitively Unimpaired Older Population with Elevated Cerebral Amyloid in a 4.5-Year Clinical Trial

The Journal of Prevention of Alzheimer s Disease(2024)10.14283/jpad.2024.138

N/A

0DataRank · unranked

0 citations

K.C. Holdridge, Michele Mancini, Michael S. Rafii, M. Case, Chakib Battioui +4 more